About the Meeting

The goal of this Clinical Trial Planning meeting is to understand key molecular and genetic 'drivers' of ER-positive cancers that may be targeted to improve outcomes and to recommend directions for future clinical trials in the treatment of ER-positive breast cancer. The meeting will address strategies to improve outcomes from clinical trials of any class of treatment in any stage of disease, including a scientific focus on overcoming mechanisms of resistance to hormonal therapy. The goal of the meeting is to have an interactive discussion, which leads to clear deliverables in terms of developing new clinical trials in ER-positive breast cancer within a few months of the meeting.


Go to www.cancer.gov Go to www.nih.gov Go to www.cancer.gov